๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Head and Neck Squamous Cell Carcinoma (HNSCC)
Clinical trial register · China

Head and Neck Squamous Cell Carcinoma (HNSCC) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 3 Chengdu 2 Shanghai 2 Shenyang 1 Hangzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou3 Chengdu2 Shanghai2 Shenyang1 Hangzhou1
All 5 locations
Target enrolment
to

Head and Neck Squamous Cell Carcinoma (HNSCC) trials in China

10 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy
NCT07545967Head and Neck Squamous Cell Carcinoma HNSCC
West China Hospital
Phase 1
6
Chengdu
2026-04-23
Recruiting
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07601737Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Head & Neck Cancer, Neoadjuvant Therapy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
182
Shanghai
2026-04-20
Recruiting
Becotatug Vedotin Plus Pucotenlimab and Platinum Chemotherapy in Locally Advanced Epidermal Growth Factor Receptor (EGFR)-Positive Head and Neck Squamous Cell Carcinoma
NCT07814287Head and Neck Squamous Cell Carcinoma, HNSCC
Xuekui Liu
Phase 2
40
Guangzhou
2026-04-15
Recruiting
GV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study
NCT07457281Head and Neck Squamous Cell Carcinoma HNSCC
West China Hospital
Phase 1
9
Chengdu
2026-04-01
Not yet open
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07393477Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC
Sir Run Run Shaw Hospital
Phase 2
30
Hangzhou
2026-02
Active, closed
Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma
NCT06673693Head and Neck Squamous Cell Carcinoma (HNSCC), HNSCC
Sun Yat-sen University
Phase 2
24
Guangzhou
2025-06-25
Recruiting
AK129 Combination Therapy for Advanced Solid Tumors
NCT06943820Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Adenocarcinoma, Advanced Solid Tumors
Akeso
Phase 1/2
230
Shenyang
2025-05-21
Not yet open
Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT06814067Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC
Fudan University
Phase 2
80
Shanghai
2025-02-10
Recruiting
Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma
NCT06630780Head and Neck Squamous Cell Carcinoma (HNSCC)
Sun Yat-sen University
Not applicable
50
Guangzhou
2024-09-26
Active, closed
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPSโ‰ฅ20 HNSCC
NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc
Phase 2/3
410
2024-05-14
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/head-and-neck-squamous-cell-carcinoma-hnscc

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Head and Neck Squamous Cell Carcinoma (HNSCC).

How many Head and Neck Squamous Cell Carcinoma (HNSCC) trials are recruiting in China?

6 of the 10 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Head and Neck Squamous Cell Carcinoma (HNSCC)), 10 studies
PhaseStudiesRecruitingShare
Phase 25250%
Phase 12220%
Not applicable1110%
Phase 1/21110%
Phase 2/31010%

Most active sponsors

Lead sponsors with the most studies (Head and Neck Squamous Cell Carcinoma (HNSCC))
Lead sponsorStudiesRecruiting
Sun Yat-sen University21
West China Hospital22
Akeso11
Fudan University10
Inhibrx Biosciences, Inc10
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine11
Sir Run Run Shaw Hospital10
Xuekui Liu11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.